高级检索
当前位置: 首页 > 详情页

The growing deaths from non-communicable diseases attributable to sugar-sweetened beverages among young and middle-aged adults: Analysis and projection based on Global Burden of Disease Study 2021

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ ESCI

机构: [1]Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, 1 Dong Jiao Min Xiang, Beijing 100730, Peoples R China [2]Capital Med Univ, Beijing Tongren Hosp, Beijing Diabet Inst, Beijing, Peoples R China [3]Capital Med Univ, Sch Biomed Engn, Dept Math, Beijing, Peoples R China
出处:
ISSN:

关键词: Global Burden of Disease 2021 Non-communicable diseases Sugar-sweetened beverages Death Socio-demographic index

摘要:
Introduction: Despite rising global health concerns about sugar-sweetened beverages (SSBs), their long-term impact on non-communicable disease (NCD) death across demographic groups and socioeconomic contexts remains poorly understood. Methods: We analyzed SSB-attributable NCD death trends using the Global Burden of Disease (GBD) Study 2021 data from 204 countries (1990-2021). Time trends in death were expressed as average annual percent change (AAPC), stratified by age and socio-demographic index (SDI). Future trends through 2051 were projected using Bayesian age-period-cohort modeling. Results: SSB-attributable deaths increased from 27,286 (95 % UI: 11,099-42,134) in 1990 to 74,657 (95 % UI: 33,724-115,575) in 2021. The age-standardized death rate rose from 0.784 to 0.889 per 100,000 (AAPC: 0.460 %, 95 % CI: 0.326-0.594). Young and middle-aged adults exhibited a rapid increase in deaths, with an AAPC of 1.250 % (95 % CI: 1.070-1.420) observed in the 25-29 age group, particularly due to chronic kidney disease (AAPC: 2.779 %, 95 % CI: 2.626-2.931). Low-middle SDI regions experienced the most dramatic increase (AAPC: 2.569 %, 95 % CI: 2.453-2.684). Conclusion: Our findings reveal an alarming rise in SSB-attributable NCD deaths, particularly affecting young adults and resource-limited regions. This growing health equity challenge requires urgent policy interventions and prevention strategies to protect vulnerable populations.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 3 区 医学
小类 | 4 区 内分泌学与代谢
最新[2025]版:
大类 | 3 区 医学
小类 | 4 区 内分泌学与代谢
JCR分区:
出版当年[2023]版:
Q1 ENDOCRINOLOGY & METABOLISM
最新[2024]版:
Q2 ENDOCRINOLOGY & METABOLISM

影响因子: 最新[2024版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版] 出版后一年[2024版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, 1 Dong Jiao Min Xiang, Beijing 100730, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, 1 Dong Jiao Min Xiang, Beijing 100730, Peoples R China [*1]Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, 1 Dong Jiao Min Xiang, Beijing 100730, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:29017 今日访问量:0 总访问量:1619 更新日期:2025-10-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)